37697481|t|The structurally diverse phytocannabinoids cannabichromene, cannabigerol and cannabinol significantly inhibit amyloid beta-evoked neurotoxicity and changes in cell morphology in PC12 cells.
37697481|a|BACKGROUND: Phytocannabinoids have been shown to inhibit the aggregation and neurotoxicity of the neurotoxic Alzheimer's disease protein beta amyloid (Abeta). We characterised the capacity of six phytocannabinoids: cannabichromene, cannabigerol, cannabinol, cannabidivarin, cannabidiol and Delta9 -tetrahydrocannabinol, to disrupt Abeta aggregation and protect against Abeta-evoked neurotoxicity in PC12 cells. METHODS: Neuroprotection against lipid peroxidation and Abeta-induced cytotoxicity was assessed using the MTT assay. Transmission electron microscopy was used to visualise phytocannabinoid effects on Abeta aggregation and fluorescence microscopy, with morphometrics and principal component analysis to assess PC12 cell morphology. RESULTS: Cannabidiol inhibited lipid peroxidation with no significant effect on Abeta toxicity, while cannabinol, cannabidivarin and cannabigerol provided neuroprotection. Cannabichromene, cannabigerol and cannabinol inhibited Abeta1-42 -induced neurotoxicity in PC12 cells, as did Delta9 -tetrahydrocannabinol, cannabidiol and cannabidivarin. Cannabichromene, cannabinol and cannabidivarin inhibited Abeta aggregation, while Delta9 -tetrahydrocannabinol reduced aggregate density. Abeta1-42 induced morphological changes in PC12 cells, including a reduction in neuritic projections and rounded cell morphology. Cannabichromene and cannabigerol inhibited this effect, while Delta9 -tetrahydrocannabinol, cannabidiol and cannabidivarin did not alter Abeta1-42 effects on cell morphology. CONCLUSIONS: These findings highlight the neuroprotective activity of cannabichromene, cannabigerol and cannabinol as novel phytocannabinoids associated with variable effects on Abeta-evoked neurite damage and inhibition of amyloid beta aggregation.
37697481	25	42	phytocannabinoids	Chemical	-
37697481	43	58	cannabichromene	Chemical	MESH:C010695
37697481	60	72	cannabigerol	Chemical	MESH:C037036
37697481	77	87	cannabinol	Chemical	MESH:D002187
37697481	130	143	neurotoxicity	Disease	MESH:D020258
37697481	178	182	PC12	CellLine	CVCL:0481
37697481	202	219	Phytocannabinoids	Chemical	-
37697481	267	280	neurotoxicity	Disease	MESH:D020258
37697481	288	298	neurotoxic	Disease	MESH:D020258
37697481	299	318	Alzheimer's disease	Disease	MESH:D000544
37697481	341	346	Abeta	Gene	54226
37697481	386	403	phytocannabinoids	Chemical	-
37697481	405	420	cannabichromene	Chemical	MESH:C010695
37697481	422	434	cannabigerol	Chemical	MESH:C037036
37697481	436	446	cannabinol	Chemical	MESH:D002187
37697481	448	462	cannabidivarin	Chemical	MESH:C580853
37697481	464	475	cannabidiol	Chemical	MESH:D002185
37697481	480	508	Delta9 -tetrahydrocannabinol	Chemical	MESH:D013759
37697481	521	526	Abeta	Gene	54226
37697481	559	564	Abeta	Gene	54226
37697481	572	585	neurotoxicity	Disease	MESH:D020258
37697481	589	593	PC12	CellLine	CVCL:0481
37697481	634	639	lipid	Chemical	MESH:D008055
37697481	657	662	Abeta	Gene	54226
37697481	671	683	cytotoxicity	Disease	MESH:D064420
37697481	707	710	MTT	Chemical	MESH:C070243
37697481	773	789	phytocannabinoid	Chemical	-
37697481	801	806	Abeta	Gene	54226
37697481	910	914	PC12	CellLine	CVCL:0481
37697481	941	952	Cannabidiol	Chemical	MESH:D002185
37697481	963	968	lipid	Chemical	MESH:D008055
37697481	1012	1017	Abeta	Gene	54226
37697481	1018	1026	toxicity	Disease	MESH:D064420
37697481	1034	1044	cannabinol	Chemical	MESH:D002187
37697481	1046	1060	cannabidivarin	Chemical	MESH:C580853
37697481	1065	1077	cannabigerol	Chemical	MESH:C037036
37697481	1104	1119	Cannabichromene	Chemical	MESH:C010695
37697481	1121	1133	cannabigerol	Chemical	MESH:C037036
37697481	1138	1148	cannabinol	Chemical	MESH:D002187
37697481	1178	1191	neurotoxicity	Disease	MESH:D020258
37697481	1195	1199	PC12	CellLine	CVCL:0481
37697481	1214	1242	Delta9 -tetrahydrocannabinol	Chemical	MESH:D013759
37697481	1244	1255	cannabidiol	Chemical	MESH:D002185
37697481	1260	1274	cannabidivarin	Chemical	MESH:C580853
37697481	1276	1291	Cannabichromene	Chemical	MESH:C010695
37697481	1293	1303	cannabinol	Chemical	MESH:D002187
37697481	1308	1322	cannabidivarin	Chemical	MESH:C580853
37697481	1333	1338	Abeta	Gene	54226
37697481	1358	1386	Delta9 -tetrahydrocannabinol	Chemical	MESH:D013759
37697481	1457	1461	PC12	CellLine	CVCL:0481
37697481	1544	1559	Cannabichromene	Chemical	MESH:C010695
37697481	1564	1576	cannabigerol	Chemical	MESH:C037036
37697481	1606	1634	Delta9 -tetrahydrocannabinol	Chemical	MESH:D013759
37697481	1636	1647	cannabidiol	Chemical	MESH:D002185
37697481	1652	1666	cannabidivarin	Chemical	MESH:C580853
37697481	1789	1804	cannabichromene	Chemical	MESH:C010695
37697481	1806	1818	cannabigerol	Chemical	MESH:C037036
37697481	1823	1833	cannabinol	Chemical	MESH:D002187
37697481	1843	1860	phytocannabinoids	Chemical	-
37697481	1897	1902	Abeta	Gene	54226
37697481	1910	1924	neurite damage	Disease	MESH:D058225
37697481	Negative_Correlation	MESH:C010695	54226
37697481	Positive_Correlation	MESH:D058225	54226
37697481	Negative_Correlation	MESH:D002185	MESH:D020258
37697481	Negative_Correlation	MESH:C010695	MESH:D020258
37697481	Association	MESH:D002187	MESH:D058225
37697481	Negative_Correlation	MESH:C037036	MESH:D020258
37697481	Association	MESH:C037036	MESH:D058225
37697481	Negative_Correlation	MESH:C580853	MESH:D020258
37697481	Association	MESH:D000544	54226
37697481	Positive_Correlation	MESH:D020258	54226
37697481	Negative_Correlation	MESH:C580853	54226
37697481	Negative_Correlation	MESH:D013759	54226
37697481	Association	MESH:C010695	MESH:D058225
37697481	Negative_Correlation	MESH:D002185	MESH:D008055
37697481	Association	MESH:D064420	54226
37697481	Negative_Correlation	MESH:D002187	MESH:D020258
37697481	Negative_Correlation	MESH:D002187	54226

